Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1982 Aug 1;156(2):634-9.
doi: 10.1084/jem.156.2.634.

Selective abrogation of antigen-specific human B cell responses by antigen-ricin conjugates

Selective abrogation of antigen-specific human B cell responses by antigen-ricin conjugates

D J Volkman et al. J Exp Med. .

Abstract

The feasibility of selectively eliminating human antigen-specific B cell responses by treating cells in vitro with antigen covalently linked to a cell toxin was examined. Tetanus toxoid (TT) was conjugated to the toxin ricin via a thioether linkage. Peripheral blood mononuclear cells from recently immunized subjects were preincubated for 2 h with TT-ricin in the presence of lactose. Antigen was then removed, and the cells from recently immunized subjects were preincubated for 2 h with TT-ricin in the presence of lactose. Antigen was then removed, and the cells were stimulated with pokeweed mitogen to induce antibody production. TT-specific antibody production was completely abrogated by preincubation with TT-ricin but not by TT alone or a mixture of TT and ricin. In contrast, polyclonal immunoglobulin production was not diminished by TT-ricin. This selective abrogation was also seen when B cells alone were preincubated with TT-ricin and a source of T cell help was later provided. T cell blastogenic responses to TT remained intact after TT-ricin exposure. Thus, antigen-toxin conjugates are capable of selectively eliminating specific antibody-producing B cell clones, while leaving intact the remainder of the B cell repertoire.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Scand J Clin Lab Invest Suppl. 1968;97:77-89 - PubMed
    1. J Biol Chem. 1977 Feb 25;252(4):1505-14 - PubMed
    1. J Allergy Clin Immunol. 1980 Jul;66(1):5-17 - PubMed
    1. Proc Natl Acad Sci U S A. 1980 Sep;77(9):5419-23 - PubMed
    1. Proc Natl Acad Sci U S A. 1980 Sep;77(9):5483-6 - PubMed